![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0228.jpg)
20.2 Notes to the consolidated financial statements for the year ended December 31, 2016
FINANCIAL INFORMATION CONCERNING ASSETS,
FINANCIAL POSITION AND FINANCIAL PERFORMANCE
20
NOTE 18.
OTHER OPERATING RECEIVABLES
CONTINUING OPERATIONS
(in millions of euros)
December 31, 2016
December 31, 2015
French State
106
326
Advances and down payments to suppliers
106
142
Miscellaneous accounts receivable
29
347
Financial instruments
10
41
Other
0
9
TOTAL
252
865
During the 2015 and 2016 financial years, AREVA disposed of tax receivables
without recourse to financial institutions in the amounts of 122 million euros and
70 million euros respectively. AREVA retained no significant ongoing involvement
in respect of these receivables.
“Miscellaneous accounts receivable” includes prepaid expenses, receivables from
suppliers and receivables from employees and benefit management bodies.
“Financial instruments” include the fair value of derivatives hedging market
transactions and the fair value of the firm commitments hedged.
At December 31, 2016, other operating receivables had a maturity of less than
one year.
OPERATIONS HELD FOR SALE
(in millions of euros)
December 31, 2016
December 31, 2015
Operations held for sale in 2015
New NP
942
792
AREVA TA
23
29
Nuclear Measurements
-
4
Sub-total
965
824
Operations held for sale in 2016
NewCo
568
TOTAL (*)
1,533
824
* see note 3.
NOTE 19.
CASH AND CASH EQUIVALENTS
CONTINUING OPERATIONS
(in millions of euros)
December 31, 2016
December 31, 2015
Cash and current accounts
483
336
Cash equivalents
202
468
TOTAL
686
804
Cash equivalents consist chiefly of short-term marketable securities and mutual
funds.
At December 31, 2016, continuing operations did not have unavailable cash and
cash equivalents (compared with 78 million euros at December 31, 2015).
226
2016 AREVA
REFERENCE DOCUMENT